Ingevity Q3 net sales down 7% to $446M; adjusts FY EBITDA guidance to $375-390M, plans restructuring

Ingevity Corp

2023-Q3 EPS reported $3.03 revenue$1,320,400,000

Net sales $446M (-7% YoY); net income $25.2M ($0.69 EPS); adjusted EPS $1.21.
Adjusted EBITDA $110.4M, margin 24.8%; operating cash flow $106.9M, free cash flow $73.4M.
Updated FY2023 adjusted EBITDA guidance to $375-$390M.
Announced closure of DeRidder, LA facility and company-wide restructuring to reposition Performance Chemicals.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Ingevity Corp reported the three and nine months ended September 30, 2023 results: revenue $446.0 million, net income $25.2 million, EPS $0.69.

Period: the three and nine months ended September 30, 2023
Revenue: $446.0 million
Net income: $25.2 million
EPS: $0.69
Result: preliminary results

Exact text from the filing

Ingevity reports third quarter 2023 financial results HIGHLIGHTS : (comparisons versus prior year period) • Net sales of $446.0 million, down 7%, compared to a record prior year • Net income of $25.2 million and diluted earnings per share (EPS) of $0.69

View on SEC.gov

Browse all earnings releases →

Ingevity Corp filing history →

Source: SEC EDGAR

accession 0001653477-23-000054

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.